| abstract |
The present disclosure relates to the field of hematopoietic stem cell or progenitor cell transplantation. More specifically, methods, compositions and kits are provided that improve proliferation and engraftment of hematopoietic stem cells or progenitor cells by co-culture and administration with endothelial cells. The methods, compositions and kits are useful for the treatment of various disorders associated with hematopoietic failure caused by disease or myeloablative treatment. |